Stockscreener 앱 받기
12.25
4.97%
-0.64
시간 외 거래:
12.39
0.14
+1.14%
전일 마감가:
$12.89
열려 있는:
$12.89
하루 거래량:
1.54M
Relative Volume:
1.77
시가총액:
$1.31B
수익:
$1.53B
순이익/손실:
$40.23M
주가수익비율:
24.50
EPS:
0.5
순현금흐름:
$60.93M
1주 성능:
-27.30%
1개월 성능:
-36.16%
6개월 성능:
-50.56%
1년 성능:
-51.58%
1일 변동 폭
$12.12
$12.89
1주일 범위
$11.60
$14.79
52주 변동 폭
$11.60
$32.66
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
명칭
Integra Lifesciences Holdings Corp
전화
(609) 275-0500
주소
1100 CAMPUS ROAD, PRINCETON, NJ
IART을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
12.25 | 1.31B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-31 | 업그레이드 | Argus | Hold → Buy |
| 2024-12-02 | 개시 | Morgan Stanley | Underweight |
| 2024-10-07 | 업그레이드 | BTIG Research | Sell → Neutral |
| 2024-07-30 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-07-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2024-05-07 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-12-05 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | 개시 | CL King | Buy |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-08 | 다운그레이드 | Argus | Buy → Hold |
| 2023-05-24 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-25 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2021-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-15 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-05-27 | 개시 | Citigroup | Neutral |
| 2020-04-03 | 개시 | SunTrust | Buy |
| 2020-01-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | 개시 | SunTrust | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-07 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-07-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Neutral |
| 2018-01-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-05-02 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | 개시 | UBS | Buy |
모두보기
Integra Lifesciences Holdings Corp 주식(IART)의 최신 뉴스
Integra Lifesciences (IART): Analyst Lowers Price Target to $25 | IART Stock News - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cable One, Inc. - GlobeNewswire Inc.
Integra LifeSciences stock target cut to $25 by JMP - Investing.com
Integra LifeSciences (IART) Sees Lowered Price Target Amid Market Reaction | IART Stock News - GuruFocus
JPMorgan Chase & Co. Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - Defense World
Wells Fargo & Company Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - Defense World
U.S. Regenerative Artificial Skin Market 2025-2032: Top Trends - openPR.com
Integra LifeSciences (NASDAQ:IART) Shares Gap Down Following Weak Earnings - Defense World
Integra LifeSciences (IART) Faces Adjusted Price Target Amid Rev - GuruFocus
Integra LifeSciences (IART) Faces Adjusted Price Target Amid Revenue Concerns | IART Stock News - GuruFocus
Wells Fargo Lowers Price Target for Integra Lifesciences (IART) - GuruFocus
JP Morgan Adjusts Price Target for Integra Lifesciences (IART) | IART Stock News - GuruFocus
Wells Fargo Lowers Price Target for Integra Lifesciences (IART) | IART Stock News - GuruFocus
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2025 Earnings Call Transcript - Insider Monkey
Attention Long-Term Shareholders of Integra LifeSciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office is Inv - GlobeNewswire
Wells Fargo Adjusts Integra LifeSciences (IART) Price Target | I - GuruFocus
Raymond James Financial Inc. Makes New Investment in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra Lifesciences Holdings Corp (IART) Q1 2025 Earnings Call Highlights: Navigating ... - Yahoo Finance
Integra LifeSciences (IART) Reports Q1 2025 Results and Strategi - GuruFocus
Stock Hits Across The Board As Companies Adjust Expectations - Finimize
Integra Lifesciences Q1 2025 Earnings: Adjusted EPS of $0.41 Bea - GuruFocus
Integra LifeSciences (IART) Q1 Earnings: Misses EPS, Exceeds Rev - GuruFocus
Integra LifeSciences (IART) Reports Q1 2025 Results and Strategic Moves - GuruFocus
Integra: Q1 Earnings Snapshot - The Washington Post
Integra LifeSciences Q1 2025 Earnings Call Transcript - MarketBeat
Long-Term Shareholders Have Rights – If You Hold Akero - GlobeNewswire
Long-Term Shareholders Have Rights – If You Hold Akero Therapeutics, Inc. (NASDAQ: AKRO); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); or Virtu Financial Inc. (NASDAQ: VIRT), Contact Grabar La - TradingView
Earnings call transcript: Integra LifeSciences misses Q1 2025 targets, stock plunges - Investing.com
Integra Lifesciences Holdings Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Integra LifeSciences misses Q1 estimates, shares fall 4% - Investing.com
Integra LifeSciences Slashes FY25 Adj. EPS OutlookUpdate - Nasdaq
Integra Lifesciences Q1 2025 Earnings: Adjusted EPS of $0.41 Beats Estimates, Revenue Hits $382.7 Million - GuruFocus
Integra LifeSciences (IART) Q1 Earnings: Misses EPS, Exceeds Revenue Expectations - GuruFocus
Integra LifeSciences Reports First Quarter 2025 Financial Results - TradingView
Integra LifeSciences (IART) Reports Q1 Revenue Surpassing Expectations | IART Stock News - GuruFocus
Integra LifeSciences (NASDAQ:IART) Reports Q1 In Line With Expectations But Quarterly Revenue Guidance Significantly Misses Expectations - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Earnings To Watch: Integra Lifesciences Holdings Corp (IART) Rep - GuruFocus
Stock Performance Spotlight: Integra Lifesciences Holdings Corp (IART) Ends the Day at 16.44, Up by 0.31 - DWinneX
Is Integra Lifesciences Holdings Corp (IART) a good investment opportunity? - uspostnews.com
The Future of Integra Lifesciences Holdings Corp: Analyzing IART - investchronicle.com
An Analysis of Integra Lifesciences Holdings Corp (IART)’s Potential Price Growth - knoxdaily.com
Notice to Long-Term Shareholders of Integra Lifesciences Holdings Corporation (NASDAQ: IART); Methode Electronics, Inc. (NYSE: MEI); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investig - GlobeNewswire
Analysts Set Integra LifeSciences Holdings Co. (NASDAQ:IART) Target Price at $22.71 - Defense World
Integra Lifesciences Holdings Corp (NASDAQ:IART) Price Forecast For The Next 12 Months Is Set At 86. - Marketing Sentinel
Notice to Long-Term Shareholders of Integra Lifesciences - GlobeNewswire
Integra Lifesciences Holdings Corp (IART) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Sete News
IART Stock Sees Surge of Approximately 1.12% in Last Five Days - knoxdaily.com
Notice to Long-Term Shareholders of BioAge Labs, Inc. - GlobeNewswire
Post-Trade Analysis: Integra Lifesciences Holdings Corp (IART) Climbs 3.16, Closing at 15.67 - DWinneX
Integra LifeSciences stock hits 52-week low at $15.45 - Investing.com
Integra Lifesciences Holdings Corp (IART) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
0.79%
자본화:
|
볼륨(24시간):